• Tue news: Pfizer explores sale of hospital drugs unit. FDA declines full approval of Ocaliva. AZ better than expected Q3 results. Pfizer, Lilly telehealth platforms draw scrutiny. 23andMe cutting lays off 40%. See more on our front page

New posts

Post thread…
What's new New posts New profile posts Latest activity
CEO tenure and stock performance
Replies
4
Views
582
Biogen
anonymous
CV/Renal Specialty Layoff
Replies
30
Views
5K
AstraZeneca
anonymous
CELT
Replies
3
Views
323
Genentech
anonymous
Transparent
Replies
2
Views
57
Intercept Pharma
anonymous
Employer Groups
Replies
4
Views
160
Exact Sciences
anonymous
Phathom
Replies
1K
Views
226K
Phathom Pharmaceuticals
anonymous
This Is an emergency situation and third announcement
Replies
4
Views
89
Johnson & Johnson
anonymous
Layoffs 100%
Replies
38
Views
4K
Boehringer Ingelheim
anonymous
RFKjr TO CLEAN UP BIG PHARMA CORRUPTION
Replies
9
Views
298
Acorda Therapeutics
anonymous
Stock uptick
Replies
4
Views
453
Bristol-Myers Squibb
anonymous
Abbott Vascular Clonmel
Replies
4K
Views
1M
Abbott
anonymous
Sotyktu Layoff Details
Replies
3
Views
344
Bristol-Myers Squibb
anonymous
RFK not good
Replies
4
Views
336
Novo Nordisk
anonymous
Stressed
Replies
5
Views
443
Novo Nordisk
anonymous
What divisions/businesses do you think Medtronic will sell-off/spin-off soon?
Replies
83
Views
27K
Medtronic
anonymous
$34 whats next Joe ?
Replies
5
Views
514
Baxter
anonymous
This week 3rd party verifying office contact as well as presentations in all offices in my territory
Replies
2
Views
70
Amgen
anonymous
CVM VEHICLES
Replies
7
Views
593
Johnson & Johnson
anonymous
Make Astellas Great Again
Replies
5
Views
2K
Astellas
anonymous
Bruce
Replies
34
Views
7K
Enzo Laboratories
anonymous
Top Bottom
Back
Post thread…